E09.352
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.352 refers to a specific type of diabetes mellitus that is caused by medication or chemical exposure. This form of diabetes is characterized by the development of proliferative diabetic retinopathy, a serious eye condition that can lead to traction retinal detachment involving the macula. Such eye complications can significantly impact vision and quality of life, making awareness and understanding of this condition important.
Causes & Symptoms
Clinical Causes: Certain medications or chemicals that interfere with insulin production or use Prolonged exposure to harmful substances or drugs known to affect blood sugar levels Underlying health conditions that increase vulnerability to medication side effects
Key Symptoms: Sudden changes in vision or blurred vision Floaters or spots in the field of vision Dark patches or shadow over part of the visual field Decreased visual acuity or sharpness Possible eye discomfort or redness
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and specialized eye tests. The diagnosis process may include:
Treatment Protocols: Management of this condition focuses on controlling blood sugar levels and addressing eye complications. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is E09.352 a billable ICD-10 code?
Yes, E09.352 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.352?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula and any associated comorbidities for accurate reporting.
Cite this Clinical Reference